Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1962 1
1964 1
1966 1
1967 2
1968 3
1970 5
1971 2
1973 1
1974 2
1975 2
1976 1
1979 1
1980 1
1981 1
1982 6
1983 1
1984 3
1985 2
1986 3
1987 3
1988 1
1989 4
1990 8
1991 3
1992 1
1993 5
1994 3
1995 4
1996 3
1997 6
1998 2
1999 10
2000 10
2001 12
2002 11
2003 17
2004 4
2005 10
2006 11
2007 12
2008 19
2009 22
2010 17
2011 25
2012 25
2013 23
2014 22
2015 25
2016 27
2017 28
2018 31
2019 27
2020 42
2021 37
2022 45
2023 35
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

579 results

Results by year

Filters applied: . Clear all
Page 1
Response.
Tashiro H, Kuwahara Y, Takahashi K, Sueoka-Aragane N. Tashiro H, et al. Among authors: kuwahara y. Chest. 2023 Jun;163(6):e286. doi: 10.1016/j.chest.2023.02.013. Chest. 2023. PMID: 37295890 No abstract available.
Dysautonomia associated with immune checkpoint inhibitors.
Tezuka T, Okuzumi S, Nakashima C, Ide T, Imai S, Mitsuboshi S, Kuwahara Y, Takizawa T, Seki M, Minematsu N, Aragane N, Nakahara J, Hori S, Nakane S, Suzuki S. Tezuka T, et al. Among authors: kuwahara y. J Neurol. 2023 Jul;270(7):3413-3423. doi: 10.1007/s00415-023-11667-5. Epub 2023 Mar 20. J Neurol. 2023. PMID: 36939931 Review.
Natural killer cell immunotherapy in glioblastoma.
Hosseinalizadeh H, Habibi Roudkenar M, Mohammadi Roushandeh A, Kuwahara Y, Tomita K, Sato T. Hosseinalizadeh H, et al. Among authors: kuwahara y. Discov Oncol. 2022 Oct 28;13(1):113. doi: 10.1007/s12672-022-00567-1. Discov Oncol. 2022. PMID: 36305981 Free PMC article. Review.
Pharmacological Targeting of Ferroptosis in Cancer Treatment.
Valashedi MR, Nikoo A, Najafi-Ghalehlou N, Tomita K, Kuwahara Y, Sato T, Roushandeh AM, Roudkenar MH. Valashedi MR, et al. Among authors: kuwahara y. Curr Cancer Drug Targets. 2022;22(2):108-125. doi: 10.2174/1568009621666211202091523. Curr Cancer Drug Targets. 2022. PMID: 34856903 Review.
Therapeutic potential for KCC2-targeted neurological diseases.
Tomita K, Kuwahara Y, Igarashi K, Kitanaka J, Kitanaka N, Takashi Y, Tanaka KI, Roudkenar MH, Roushandeh AM, Kurimasa A, Nishitani Y, Sato T. Tomita K, et al. Among authors: kuwahara y. Jpn Dent Sci Rev. 2023 Dec;59:431-438. doi: 10.1016/j.jdsr.2023.11.001. Epub 2023 Nov 11. Jpn Dent Sci Rev. 2023. PMID: 38022385 Free PMC article. Review.
Overcoming clinical resistance to EZH2 inhibition using rational epigenetic combination therapy.
Kazansky Y, Cameron D, Mueller HS, Demarest P, Zaffaroni N, Arrighetti N, Zuco V, Kuwahara Y, Somwar R, Ladanyi M, Qu R, De Stanchina E, Dela Cruz FS, Kung AL, Gounder M, Kentsis A. Kazansky Y, et al. Among authors: kuwahara y. bioRxiv [Preprint]. 2023 Dec 1:2023.02.06.527192. doi: 10.1101/2023.02.06.527192. bioRxiv. 2023. PMID: 36798379 Free PMC article. Updated. Preprint.
Impact of obesity in asthma: Possible future therapies.
Tashiro H, Kurihara Y, Kuwahara Y, Takahashi K. Tashiro H, et al. Among authors: kuwahara y. Allergol Int. 2024 Jan;73(1):48-57. doi: 10.1016/j.alit.2023.08.007. Epub 2023 Sep 1. Allergol Int. 2024. PMID: 37659887 Free article. Review.
Cashing in on ferroptosis against tumor cells: Usher in the next chapter.
Valashedi MR, Najafi-Ghalehlou N, Nikoo A, Bamshad C, Tomita K, Kuwahara Y, Sato T, Roushandeh AM, Roudkenar MH. Valashedi MR, et al. Among authors: kuwahara y. Life Sci. 2021 Nov 15;285:119958. doi: 10.1016/j.lfs.2021.119958. Epub 2021 Sep 14. Life Sci. 2021. PMID: 34534562 Review.
Mitochondria: how eminent in ageing and neurodegenerative disorders?
Bamshad C, Najafi-Ghalehlou N, Pourmohammadi-Bejarpasi Z, Tomita K, Kuwahara Y, Sato T, Feizkhah A, Roushnadeh AM, Roudkenar MH. Bamshad C, et al. Among authors: kuwahara y. Hum Cell. 2023 Jan;36(1):41-61. doi: 10.1007/s13577-022-00833-y. Epub 2022 Nov 29. Hum Cell. 2023. PMID: 36445534 Review.
Overcoming clinical resistance to EZH2 inhibition using rational epigenetic combination therapy.
Kazansky Y, Cameron D, Mueller HS, Demarest P, Zaffaroni N, Arrighetti N, Zuco V, Kuwahara Y, Somwar R, Ladanyi M, Qu R, de Stanchina E, Dela Cruz FS, Kung AL, Gounder MM, Kentsis A. Kazansky Y, et al. Among authors: kuwahara y. Cancer Discov. 2024 Feb 5. doi: 10.1158/2159-8290.CD-23-0110. Online ahead of print. Cancer Discov. 2024. PMID: 38315003
579 results